Ensign Peak Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Ensign Peak Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Hold	40,850	–	–	﹤0.01%	800
2026 Q1	$1.23M	Sell	40,850 -6,000	-13%	-$193K	﹤0.01%	797
2025 Q4	$1.46M	Hold	46,850	–	–	﹤0.01%	759
2025 Q3	$946K	Sell	46,850 -23,000	-33%	-$404K	﹤0.01%	1060
2025 Q2	$1.17M	Sell	69,850 -6,500	-9%	-$105K	﹤0.01%	1151
2025 Q1	$1.17M	Sell	76,350 -5,850	-7%	-$104K	﹤0.01%	1163
2024 Q4	$1.81M	Hold	82,200	–	–	﹤0.01%	986
2024 Q3	$1.48M	Hold	82,200	–	–	﹤0.01%	1095
2024 Q2	$1.34M	Hold	82,200	–	–	﹤0.01%	1108
2024 Q1	$1.16M	Hold	82,200	–	–	﹤0.01%	1221
2023 Q4	$858K	Hold	82,200	–	–	﹤0.01%	1465
2023 Q3	$838K	Hold	82,200	–	–	﹤0.01%	1329
2023 Q2	$619K	Hold	82,200	–	–	﹤0.01%	1560
2023 Q1	$727K	Buy	82,200 +15,700	+24%	+$155K	﹤0.01%	1484
2022 Q4	$606K	Buy	66,500 +12,050	+22%	+$105K	﹤0.01%	1552
2022 Q3	$439K	Buy	54,450 +7,050	+15%	+$62.3K	﹤0.01%	1530
2022 Q2	$356K	Buy	47,400 +1,550	+3%	+$13.5K	﹤0.01%	1607
2022 Q1	$431K	Hold	45,850	–	–	﹤0.01%	1609
2021 Q4	$367K	Buy	45,850 +1,500	+3%	+$13.5K	﹤0.01%	1741
2021 Q3	$432K	Hold	44,350	–	–	﹤0.01%	1652
2021 Q2	$439K	Buy	44,350 +7,500	+20%	+$79.4K	﹤0.01%	1616
2021 Q1	$425K	Hold	36,850	–	–	﹤0.01%	1622
2020 Q4	$356K	Hold	36,850	–	–	﹤0.01%	1652
2020 Q3	$332K	Buy	+36,850	New	+$390K	﹤0.01%	1603

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Ensign Peak Advisors's TEVA Position: Q2 2026 in Review

Ensign Peak Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 40,850 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Ensign Peak Advisors first reported a position in TEVA in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.81M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Ensign Peak Advisors held 40,850 shares of Teva Pharmaceuticals worth $1.38M as of Q2 2026.
Ensign Peak Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #800 holding.
Ensign Peak Advisors first reported a position in Teva Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
Ensign Peak Advisors's Teva Pharmaceuticals position peaked at $1.81M in Q4 2024.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.